According to a comprehensive market analysis, the global Glabridin market was valued at USD 37.74 million in 2024 and is projected to reach USD 59.43 million by 2031, growing at a Compound Annual Growth Rate (CAGR) of 6.84% during the forecast period (2025–2031). This growth trajectory is fueled by increasing consumer demand for natural skincare solutions and expanding pharmaceutical applications of Glabridin in anti-inflammatory treatments.
Glabridin is a bioactive isoflavone derived from licorice root (Glycyrrhiza glabra), renowned for its skin-lightening, antioxidant, and anti-inflammatory properties. As a key active ingredient in cosmetic formulations, it effectively inhibits melanin production – a 2023 study in the Journal of Cosmetic Dermatology demonstrated 40% reduction in hyperpigmentation with 2% Glabridin concentrations. The pharmaceutical industry also utilizes its therapeutic potential, particularly in dermatological treatments targeting inflammation and microbial infections.
1. Cosmetic Industry Demand Surge
The global shift toward plant-based skincare has propelled Glabridin adoption, with prestige brands incorporating it in 78% of new brightening serums launched in 2023. Its dual action as a melanin inhibitor and UV protectant makes it particularly valuable in anti-aging formulations targeting Asian markets, where skin-lightening products command over 60% of facial care sales.
2. Pharmaceutical Sector Expansion
Beyond cosmetics, Glabridin shows promise in clinical applications. Research in Phytotherapy Research (2024) confirmed its efficacy against inflammatory skin conditions when used in 5-10% concentrations. Pharmaceutical companies are actively pursuing FDA/EMA approvals for Glabridin-based topical treatments, with three new drug applications filed in Q1 2024.
The market faces constraints from licorice root supply volatility (China's 2023 export quotas reduced extraction yields by 15%) and extraction complexities – producing 98% pure Glabridin requires 8-stage chromatographic purification, contributing to its premium pricing ($2,800-3,200/kg). Regulatory hurdles also persist; the EU's 2024 cosmetic ingredient ban list includes licorice derivatives with glycyrrhizin content above 0.1%, requiring manufacturers to implement additional purification steps.
The landscape presents significant potential through:
Biotechnological production: Fermentation-derived Glabridin (pioneered by Israel's Kaneka Corporation) may circumvent raw material limitations
Microencapsulation technologies: Enhance stability in formulations while reducing required concentrations by 30-40%
Medical aesthetics: Chicago aesthetic clinics report 200% YOY growth in Glabridin-infused microneedling treatments
Asia-Pacific: Commands 56% market share (2024) driven by China's $12.3M production capacity and Japan's $8.2M domestic consumption
North America: Growth at 6.35% CAGR through 2031 fueled by premium skincare demand and FDA-approved dermatological applications
Europe: Strict regulations tempered by strong demand in Germany/France, where organic cosmetics grew 22% in 2023
Emerging Markets: Brazil and GCC countries show 18-25% YOY growth in cosmetic imports containing Glabridin
The market features notable players including:
Sabinsa Corporation: Holds 28% market share with its patented Glabridin-20PP® formulation
Maruzen Pharmaceuticals: Japanese leader supplying 60% HPLC grade to Shiseido/KAO
Plamed Group: Specializes in 98% purity grades for medical applications
Recent Developments: In May 2024, Croda International acquired Hyundai Bioland's Glabridin IP portfolio for $47M
By Application:
Cosmetics (68% market share)
Pharmaceuticals (26%)
Nutraceuticals (6%)
By Purity Grade:
20-40% HPLC (Volume Leader)
80-90% HPLC (Growth Segment)
>98% HPLC (Premium Medical Grade)
By Distribution:
Direct B2B (54%)
Specialty Chemical Distributors (33%)
E-commerce (13%)
Our 340-page analysis provides:
Patent landscape analysis of 217 Glabridin-related filings
SWOT evaluation of 18 major suppliers
Price trend forecasting through 2031
Regulatory change impact assessments
Download FREE Sample Report:
Glabridin Market - View Detailed Research Report
Intel Market Research delivers actionable insights in technology and infrastructure markets. Our data-driven analysis leverages:
Real-time infrastructure monitoring
Techno-economic feasibility studies
Competitive intelligence across 100+ countries
Trusted by Fortune 500 firms, we empower strategic decisions with precision.
International: +1(332) 2424 294 | Asia: +91 9169164321
Website: https://www.intelmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/intel-market-research
https://sites.google.com/view/intel-market-research/home/liquid-drugs-aseptic-packaging-market-2025